Health ❯ Healthcare ❯ Research and Development

Clinical Trials

Innovative Therapies Preclinical Testing Vaccine Development Therapeutic Innovations Alzheimer's Treatments Obesity Treatment Robotic Technology Cancer Vaccines Transplantation Studies Teplizumab Efficacy Preclinical Studies Drug Efficacy and Safety Antibody-based Medicines Diabetes Research HPV Self-Collection Pilot Program Diagnostic Accuracy Exosome Research Autoimmune Diseases Povorcitinib Collaborative Medical Research Therapeutic Approaches Randomized Controlled Trials Hormonal Treatments Model Validation Interdisciplinary Collaboration in Medicine Alzheimer's Treatment Research Prototyping Emerging Treatments New Medications Diabetes Treatment Innovations Neurology Alzheimer's Disease Treatments Biomarker Studies Motor Neurone Disease Research Immunotherapy Combinations Dementia Research Therapeutics Psychiatric Disorders AI in Medicine Next-Generation Therapies

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

Regulators cited a head-to-head trial that showed about an 8% relative drop in major heart events versus Lilly’s older drug Trulicity, prompting wider use for high-risk adults with type 2 diabetes.

Silo Pharma Raises $4 Million in Private Placement as Shares Fall 28%

LEO Pharma to Acquire Replay in $50 Million Gene-Therapy Deal

Eli Lilly’s Tirzepatide Surge Collides With Rich-Valuation Concerns

Driehaus and Deerfield Lift Praxis Stakes in Q4, SEC Filings Show

Moderna Secures $1.5 Billion Loan, Outlines Path to 2028 Breakeven

Intranasal Antibody Cuts Mugwort Allergy in Mice, Paving Way for Human Trials

UC Irvine’s Iris Valve Achieves Key Preclinical Milestones